Respiratory News and Research

RSS

New approach could enable wider adoption of COVID-19 testing for diagnosis in research laboratories

Clinician-scientists at Nanyang Technological University, Singapore's (NTU Singapore) Lee Kong Chian School of Medicine (LKCMedicine) have demonstrated a way to improve the speed, handling time and cost of COVID-19 laboratory tests.

27 Jul 2020

Researchers identify anticoagulation agent that suppresses SARS-CoV-2 replication in vitro

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can cause acute respiratory distress syndrome, hypercoagulability, hypertension, and multiorgan dysfunction.

27 Jul 2020

Study identifies mechanisms that underlie olfactory symptoms of COVID-19

A new study of human olfactory cells has revealed that viral invasion of supportive cells in the nasal cavity might be driving the loss of smell seen in some patients with COVID-19.

25 Jul 2020

Olfactory cell types are most vulnerable to COVID-19 infection, shows study

Temporary loss of smell, or anosmia, is the main neurological symptom and one of the earliest and most commonly reported indicators of COVID-19.

25 Jul 2020

Higher levels of TGFBIp are correlated with severity of COVID-19 symptoms

A new study found raised levels of transforming growth factor beta-induced protein (TGFBIp) in blood sampled from roughly 100 people hospitalized for COVID-19, and further found that elevated levels of both the normal and acetylated forms of TGFBIp correlated with the severity of disease symptoms in these patients.

25 Jul 2020

Researcher receives Outstanding Investigator Award for groundbreaking microvascular and circulation research

Sarah Yuan, MD, PhD, professor and chair of the Department of Molecular Pharmacology and Physiology at the USF Health Morsani College of Medicine, has received a highly competitive National Heart, Lung, and Blood Institute (NHLBI) Outstanding Investigator Award to continue breaking new ground in microvascular and circulation research.

25 Jul 2020

MP Biomedicals and A*STAR jointly develop rapid antibody test kit for COVID-19

MP Biomedicals Asia Pacific Pte Ltd, a diagnostic corporation which has been operating for over 30 years focusing on various infectious disease testing development and manufacturing, today announced the successful development of a rapid antibody test kit for COVID-19, in collaboration with the Agency for Science, Technology and Research.

From MP Biomedicals, LLC 25 Jul 2020

Sputum testing detects COVID-19 virus at higher rates than other methods

Early and accurate detection is critical for preventing the spread of COVID-19 and providing appropriate care for patients.

24 Jul 2020

Experimental mRNA-based COVID-19 vaccine elicits protective immune responses in animals

An experimental messenger RNA (mRNA)-based vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) elicits protective immune responses in mice and non-human primates, researchers report on July 23rd in the journal Cell.

24 Jul 2020

Patients with frailty, older age and UTIs have higher risk of developing sepsis

Patients with frailty, older age and urinary tract infections are at greatest risk of developing sepsis following infection consultations in primary care, research has found.

24 Jul 2020

New app could help scientists to investigate the use of wearable devices for COVID-19 detection

The researchers, funded by National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre (BRC), created the Mass Science app that allows COVID-Collab study participants to connect wearables, such as Fitbit devices, and share data including heart rate, activity and sleep.

24 Jul 2020

An important SARS-CoV-2 enzyme is responsible for low in vivo antiviral efficacy of hydroxychloroquine

Researchers have shown that hydroxychloroquine interferes with only one redundant pathway that activates the SARS-CoV-2 spike protein.

24 Jul 2020

Pets show antibodies to SARS-CoV-2 in Italian study

A study shows that reverse transmission of SARS-CoV-2 is probable, with 3-4% of pets showing antibodies to the infection, though no virus was recovered.

24 Jul 2020

Scientists determine the origin and transmission rates of SARS-CoV-2 strains

A team of Brazilian and European scientists has determined the transmission rates and out-of-country origins of predominant SARS-CoV-2 strains currently circulating in Brazil, which harbors one of the fastest growing COVID-19 epidemics in the world.

24 Jul 2020

Researchers design new version of protein to develop COVID-19 vaccine

Responding to a need to quickly develop billions of doses of lifesaving COVID-19 vaccines, a scientific team at The University of Texas at Austin has successfully redesigned a key protein from the coronavirus, and the modification could enable much faster and more stable production of vaccines worldwide.

24 Jul 2020

Novel research determines the prevalence of chronic kidney disease

A new study looking at nearly three decades of data from some 54,000 people has determined that the overall prevalence of chronic kidney disease (CKD) for several racial/ethnic and socioeconomic groups in the United States has stabilized in recent years, except Mexican Americans.

24 Jul 2020

Factors linked to structural racism put Latinos at increased for COVID-19, study finds

Factors linked to structural racism put Latino communities in the U.S. at high risk of COVID-19, a study published today says. The new study is the first nationwide analysis of COVID-19 cases and deaths among Latinos.

23 Jul 2020

Neutralizing antibodies isolated from COVID-19 patients can quash SARS-CoV-2

Scientists across the globe are racing to study how antibodies can help suppress SARS-CoV-2, the virus that causes the coronavirus disease (COVID-19).

23 Jul 2020

Study shows interferons do not induce the expression of SARS-CoV-2 cell entry receptor

In a new bioRxiv study, authors identified a isoform of ACE2 (designated as deltaACE2 or dACE2) receptor, shown to be induced in various human cell types.

23 Jul 2020

New collaboration brings over 20,000 onsite COVID-19 tests to Detroit’s residents

A partnership among Altimetrik, a Southfield-based fast-growing global business transformation company, the 501(c)(3) Vattikutti Foundation, Henry Ford Health System and the City of Detroit has provided more than 20,000 onsite COVID-19 tests to residents in 163 of Detroit's senior and congregate living facilities, as well as the city's first responders and essential workers.

23 Jul 2020

Respiratory News and Research

New approach could enable wider adoption of COVID-19 testing for diagnosis in research laboratories

Researchers identify anticoagulation agent that suppresses SARS-CoV-2 replication in vitro

Study identifies mechanisms that underlie olfactory symptoms of COVID-19

Olfactory cell types are most vulnerable to COVID-19 infection, shows study

Higher levels of TGFBIp are correlated with severity of COVID-19 symptoms

Researcher receives Outstanding Investigator Award for groundbreaking microvascular and circulation research

MP Biomedicals and A*STAR jointly develop rapid antibody test kit for COVID-19

Sputum testing detects COVID-19 virus at higher rates than other methods

Experimental mRNA-based COVID-19 vaccine elicits protective immune responses in animals

Patients with frailty, older age and UTIs have higher risk of developing sepsis

New app could help scientists to investigate the use of wearable devices for COVID-19 detection

An important SARS-CoV-2 enzyme is responsible for low in vivo antiviral efficacy of hydroxychloroquine

Pets show antibodies to SARS-CoV-2 in Italian study

Scientists determine the origin and transmission rates of SARS-CoV-2 strains

Researchers design new version of protein to develop COVID-19 vaccine

Novel research determines the prevalence of chronic kidney disease

Factors linked to structural racism put Latinos at increased for COVID-19, study finds

Neutralizing antibodies isolated from COVID-19 patients can quash SARS-CoV-2

Study shows interferons do not induce the expression of SARS-CoV-2 cell entry receptor

New collaboration brings over 20,000 onsite COVID-19 tests to Detroit’s residents

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News